These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26574797)

  • 21. Effect of brain-derived neurotrophic factor on mouse axotomized retinal ganglion cells and phagocytic microglia.
    Galindo-Romero C; Valiente-Soriano FJ; Jiménez-López M; García-Ayuso D; Villegas-Pérez MP; Vidal-Sanz M; Agudo-Barriuso M
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):974-85. PubMed ID: 23307961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon monoxide treatment reduces microglial activation in the ischemic rat retina.
    Ulbrich F; Goebel U; Böhringer D; Charalambous P; Lagrèze WA; Biermann J
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1967-1976. PubMed ID: 27443355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.
    Wang K; Peng B; Lin B
    Glia; 2014 Dec; 62(12):1943-54. PubMed ID: 24989686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration.
    Liberatore F; Bucci D; Mascio G; Madonna M; Di Pietro P; Beneventano M; Puliti AM; Battaglia G; Bruno V; Nicoletti F; Romano MR
    Neuroscience; 2017 Nov; 363():142-149. PubMed ID: 28918254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouse.
    Sarra GM; Sarra FG; Schlichtenbrede FC; Trittibach P; Estermann S; Tsiroukis E; Ali RR; Luthert PJ; Reichel MB
    Ophthalmic Res; 2005; 37(2):72-82. PubMed ID: 15746562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation.
    Huang Z; Zhou T; Sun X; Zheng Y; Cheng B; Li M; Liu X; He C
    Cell Death Differ; 2018 Jan; 25(1):180-189. PubMed ID: 28885615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs.
    Rong X; Yang S; Miao H; Guo T; Wang Z; Shi W; Mo X; Yuan W; Jin T
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6025-34. PubMed ID: 22871834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection of photoreceptors by minocycline in light-induced retinal degeneration.
    Zhang C; Lei B; Lam TT; Yang F; Sinha D; Tso MO
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2753-9. PubMed ID: 15277501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration.
    Ebert S; Weigelt K; Walczak Y; Drobnik W; Mauerer R; Hume DA; Weber BH; Langmann T
    J Neurochem; 2009 Sep; 110(6):1863-75. PubMed ID: 19627444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal microglia are activated by systemic fungal infection.
    Maneu V; Noailles A; Megías J; Gómez-Vicente V; Carpena N; Gil ML; Gozalbo D; Cuenca N
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3578-85. PubMed ID: 24833742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinal cell type-specific prevention of ischemia-induced damages by LPS-TLR4 signaling through microglia.
    Halder SK; Matsunaga H; Ishii KJ; Akira S; Miyake K; Ueda H
    J Neurochem; 2013 Jul; 126(2):243-60. PubMed ID: 23574143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to keep injured CNS neurons viable--strategies for neuroprotection and gene transfer to retinal ganglion cells.
    Isenmann S; Schmeer C; Kretz A
    Mol Cell Neurosci; 2004 May; 26(1):1-16. PubMed ID: 15121174
    [No Abstract]   [Full Text] [Related]  

  • 34. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma.
    Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
    J Glaucoma; 2011 Feb; 20(2):100-8. PubMed ID: 20436364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of thalidomide against N-methyl-D-aspartate-induced retinal neurotoxicity.
    Takada K; Munemasa Y; Kuribayashi J; Fujino H; Kitaoka Y
    J Neurosci Res; 2011 Oct; 89(10):1596-604. PubMed ID: 21702058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
    Deliyanti D; Miller AG; Tan G; Binger KJ; Samson AL; Wilkinson-Berka JL
    Hypertension; 2012 Mar; 59(3):607-13. PubMed ID: 22275532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina.
    Kitaoka Y; Kitaoka Y; Kumai T; Lam TT; Kuribayashi K; Isenoumi K; Munemasa Y; Motoki M; Kobayashi S; Ueno S
    Brain Res; 2004 Aug; 1018(1):111-8. PubMed ID: 15262212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.
    Colafrancesco V; Coassin M; Rossi S; Aloe L
    Ann Ist Super Sanita; 2011; 47(3):284-9. PubMed ID: 21952154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation.
    Ni YQ; Xu GZ; Hu WZ; Shi L; Qin YW; Da CD
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2589-98. PubMed ID: 18515588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma.
    Liu X; Huang P; Wang J; Yang Z; Huang S; Luo X; Qi J; Shen X; Zhong Y
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):776-86. PubMed ID: 26934133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.